GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
2019-07-15 $120.72 $123.16 $120.59 $123.04 928 973
2019-07-12 $121.53 $122.03 $119.53 $120.82 1 340 037
2019-07-11 $124.20 $124.20 $120.02 $121.49 1 618 327
2019-07-10 $125.62 $127.74 $123.20 $124.37 1 740 591
2019-07-09 $124.50 $126.48 $123.34 $125.72 1 384 316
2019-07-08 $129.47 $129.47 $124.27 $125.30 1 841 109
2019-07-05 $132.71 $133.53 $129.92 $130.30 1 239 532
2019-07-03 $134.25 $134.84 $132.28 $133.35 1 017 115
2019-07-02 $131.33 $134.20 $130.30 $134.08 1 389 200
2019-07-01 $132.78 $132.98 $129.76 $131.28 1 204 817
2019-06-28 $126.64 $131.21 $126.64 $130.98 2 159 433
2019-06-27 $125.64 $127.20 $124.31 $126.11 1 021 104
2019-06-26 $125.39 $126.74 $123.10 $125.34 1 620 181
2019-06-25 $128.51 $129.00 $124.82 $125.15 1 717 476
2019-06-24 $132.45 $132.77 $126.35 $126.98 1 972 317
2019-06-21 $129.11 $132.74 $125.54 $132.39 3 357 821
2019-06-20 $124.78 $129.76 $124.78 $128.83 2 412 813
2019-06-19 $122.22 $124.04 $120.91 $123.77 807 807
2019-06-18 $122.85 $124.53 $121.91 $122.37 1 271 473
2019-06-17 $118.29 $122.08 $118.29 $120.14 1 064 016
2019-06-14 $117.34 $118.97 $116.77 $117.93 981 564
2019-06-13 $120.93 $122.93 $116.21 $117.24 1 893 376
2019-06-12 $117.11 $121.77 $116.55 $120.65 1 644 887
2019-06-11 $117.45 $118.40 $115.66 $117.14 1 326 598
2019-06-10 $118.61 $119.52 $116.35 $116.42 1 730 018
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT